Extending the US Food and Drug Administration's Postmarket Authorities.

Fernandez Lynch, Holly; Sachs, Rachel E; Lee, Sejin; Herder, Matthew; Ross, Joseph S; Ramachandran, Reshma

Fernandez Lynch, Holly; Sachs, Rachel E; Lee, Sejin; Herder, Matthew; Ross, Joseph S; Ramachandran, Reshma.

Afiliación

Fernandez Lynch H; Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Sachs RE; Carey Law School, University of Pennsylvania, Philadelphia.
Lee S; Leonard Davis Institute, University of Pennsylvania, Philadelphia.
Herder M; Washington University in St Louis School of Law, St Louis, Missouri.
Ross JS; Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Ramachandran R; Health Law Institute, Schulich School of Law, Dalhousie University, Halifax, Nova Scotia, Canada.

JAMA Health Forum ; 4(6): e231313, 2023 Jun 02.

Article en En | MEDLINE | ID: mdl-37294583

Asunto(s)

Aprobación de Drogas; Alimentos; Estados Unidos; Humanos; Preparaciones Farmacéuticas; United States Food and Drug Administration

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_medicamentos_vacinas_tecnologias Asunto principal: Aprobación de Drogas / Alimentos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: JAMA Health Forum Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google